| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,705 |
1,340 |
$82K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,225 |
2,019 |
$77K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
757 |
745 |
$51K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,020 |
1,009 |
$40K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,110 |
952 |
$36K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
339 |
323 |
$31K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
73 |
69 |
$21K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
50 |
49 |
$17K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
212 |
186 |
$8K |
| 87631 |
|
36 |
35 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
176 |
124 |
$5K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
74 |
73 |
$4K |
| 87275 |
|
266 |
260 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
65 |
37 |
$3K |
| 80053 |
Comprehensive metabolic panel |
253 |
242 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
69 |
44 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
57 |
57 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
102 |
102 |
$2K |
| 36000 |
|
236 |
222 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
265 |
249 |
$2K |
| 87428 |
|
26 |
26 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
55 |
54 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
25 |
25 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
55 |
51 |
$693.28 |
| 80061 |
Lipid panel |
40 |
40 |
$585.20 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
38 |
27 |
$448.18 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15 |
13 |
$419.20 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
57 |
57 |
$392.70 |
| 36415 |
Collection of venous blood by venipuncture |
15 |
12 |
$26.25 |
| J7050 |
Infusion, normal saline solution, 250 cc |
233 |
210 |
$8.71 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
19 |
18 |
$5.10 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
19 |
18 |
$1.80 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
41 |
40 |
$0.35 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
69 |
69 |
$0.02 |
| Q0247 |
Injection, sotrovimab, 500 mg |
65 |
61 |
$0.00 |